Top News
» » » Johnson & Johnson vaccine may increase risk of rare autoimmune disease

Johnson & Johnson vaccine may increase risk of rare autoimmune disease

13-07-2021, 11:26 Armenia » Medicine
Johnson & Johnson vaccine may increase risk of rare autoimmune disease


13 July 2021, 11:26 - NovostiNK
The use of the COVID-19 vaccine from the American company Johnson & Johnson may increase the risk of developing a rare autoimmune disease - Guillain-Barré syndrome.

According to The New York Times, the Food and Drug Administration under the US Department of Health and Human Services intends to announce this.

In patients who received this drug in the United States, about 3-5 times more often than usual, Guillain-Barré syndrome develops - an autoimmune lesion of peripheral nerves, which is accompanied by muscle weakness and sensory impairment.

According to preliminary data, about 100 cases of the syndrome have been identified among people who received this vaccine, while the risk of developing it is usually extremely low.

The regulator believes that the benefits of the Johnson & Johnson vaccine largely outweigh the potential harm.


news.am


Residents of Armenia will be exempt from the entry ban to Sweden
Residents of Armenia will be exempt from the entry ban to Sweden
As of Monday, 12 July the entry ban to Sweden will be lifted entirely...
Armenia-France cooperation in heritage field enters into new stage
Armenia-France cooperation in heritage field enters into new stage
France stands by Armenia for the preservation and restoration of the...
Moderna, Pfizer vaccines linked to mild heart inflammation
Moderna, Pfizer vaccines linked to mild heart inflammation
The Pfizer/BioNTech and Moderna jabs have been linked to cases of...

:*
E-Mail:
:
Bold Italic Underline Strike | Align left Center Align right | Insert smilies Insert link URLInsert protected URL Select color | Add Hidden Text Insert Quote Convert selected text from selection to Cyrillic (Russian) alphabet Insert spoiler
: *